Sales reported at Rs 2.91 crore
Net Loss of Vivanza Biosciences reported to Rs 0.13 crore in the quarter ended March 2021 as against net loss of Rs 0.08 crore during the previous quarter ended March 2020. Sales remain constant at Rs 2.91 crore in the quarter ended March 2021 and also during the previous quarter ended March 2020.For the full year,net profit reported to Rs 0.07 crore in the year ended March 2021 as against net loss of Rs 0.21 crore during the previous year ended March 2020. Sales rose 2.81% to Rs 9.89 crore in the year ended March 2021 as against Rs 9.62 crore during the previous year ended March 2020.
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales2.912.91 0 9.899.62 3 OPM %-2.41-2.41 -0.91-3.53 - PBDT-0.08-0.08 0 0.13-0.21 LP PBT-0.08-0.08 0 0.12-0.21 LP NP-0.13-0.08 -63 0.07-0.21 LP
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
